Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Henry L. Surprenant is active.

Publication


Featured researches published by Henry L. Surprenant.


Drug Development and Industrial Pharmacy | 2006

Development of near zero-order release dosage forms using three-dimensional printing (3-DP) technology.

Chen-Chao Wang; Monica Tejwani; Willie J. Roach; Jennifer L. Kay; Jaedeok Yoo; Henry L. Surprenant; Donald C. Monkhouse; Timothy J. Pryor

ABSTRACT Three near zero-order controlled-release pseudoephedrine hydrochloride (PEH) formulations demonstrating proportional release rates were developed using 3-Dimensional Printing (3-DP™) technology. Mixtures of Kollidon SR and hydroxypropylmethyl cellulose (HPMC) were used as drug carriers. The release rates were adjusted by varying the Kollidon SR-HPMC ratio while keeping fabrication parameters constant. The dosage forms were composed of an immediate release core and a release rate regulating shell, fabricated with an aqueous PEH and an ethanolic triethyl citrate (TEC) binder, respectively. The dosage form design called for the drug to be released via diffusional pathways formed by HPMC in the shell matrix. The release rate was shown to increase correspondingly with the fraction of HPMC contained in the polymer blend. The designed formulations resulted in dosage forms that were insensitive to changes in pH of the dissolution medium, paddle stirring rate, and the presence/absence of a sinker. The near zero-order release properties were unchanged regardless of the dissolution test being performed on either single cubes or on a group of eight cubes encased within a gelatin capsule shell. The chemical and dissolution properties of the three formulations remained unchanged following 1 months exposure to 25°C/60% RH or 40°C/75% RH environment under open container condition. The in vivo performance of the three formulations was evaluated using a single-dose, randomized, open-label, four-way crossover clinical study composed of 10 fasted healthy volunteers. The pharmacokinetic parameters were analyzed using a noncompartmental model. Qualitative rank order linear correlations between in vivo absorption profiles and in vitro dissolution parameters (with slope and intercept close to unity and origin, respectively) were obtained for all three formulations, indicating good support for a Level A in vivo/in vitro correlation.


Archive | 2002

Method and apparatus for engineered regenerative biostructures such as hydroxyapatite substrates for bone healing applications

Heather Ann Beam; Thomas J. Bradbury; Kathleen D. Chesmel; Christopher M. Gaylo; Alfred Anthony Litwak; Qing Liu; Peter A. Materna; Donald C. Monkhouse; Jennifer Patterson; Timothy J. Pryor; Sunil Saini; Henry L. Surprenant; Chen-Chao Wang; Thomas George West; Jaedeok Yoo


Archive | 2016

Three-dimensional printing system and equipment assembly

Jaedeok Yoo; Thomas J. Bradbury; Thomas J. Bebb; James Iskra; Henry L. Surprenant; Thomas George West


Archive | 2002

Method and apparatus for engineered regenerative biostructures

Heather Ann Beam; Kathleen D. Chesmel; Thomas J. Bradbury; Christopher M. Gaylo; Alfred Anthony Litwak; Qing Liu; Peter A. Materna; Donald C. Monkhouse; Jennifer Patterson; Timothy J. Pryor; Sunil Saini; Henry L. Surprenant; Chen-Chau Wang; Thomas George West; Jaedeok Yoo


Archive | 2007

Dosage forms and methods of use thereof

Jae D. Yoo; Henry L. Surprenant; Donald C. Monkhouse; Thomas George West


Archive | 2014

Rapid disperse dosage form containing levetiracetam

Jules Jacob; Norman Coyle; Thomas George West; Donald C. Monkhouse; Henry L. Surprenant; Nemichand B. Jain


Archive | 2015

Rapidly dispersible dosage form of topiramate

Jules Jacob; Lauren Beach; Thomas George West; Donald C. Monkhouse; Henry L. Surprenant


Archive | 2017

RAPID DISPERSE DOSAGE FORM

Jules Jacob; Norman Coyle; Thomas George West; Donald C. Monkhouse; Henry L. Surprenant; Nemichand B. Jain


Archive | 2014

Schnell zerfallende darreichungsform von topiramat

Jules Jacob; Lauren Beach; Thomas George West; Donald C. Monkhouse; Henry L. Surprenant


Archive | 2014

Forme posologique à dispersion rapide de topiramate

Jules Jacob; Lauren Beach; Thomas George West; Donald C. Monkhouse; Henry L. Surprenant

Collaboration


Dive into the Henry L. Surprenant's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald C. Monkhouse

Rensselaer Polytechnic Institute

View shared research outputs
Top Co-Authors

Avatar

Jaedeok Yoo

Massachusetts Institute of Technology

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Qing Liu

Princeton University

View shared research outputs
Top Co-Authors

Avatar
Researchain Logo
Decentralizing Knowledge